Dr. Michael Ackermann Ph.D.

Dr. Michael Ackermann, PhD, MBA has an extensive work experience in various leadership roles. Dr. Michael co-founded Arrivo BioVentures LLC in 2015, where they currently serve as a board member and chief business officer. In 2021, they became the managing director of Solas BioVentures. Dr. Michael is also a board member of transOMIC technologies inc. since 2019 and Revibe Technologies since 2022. Additionally, Dr. Ackermann is the co-founder and president of AB Collaborative Investment, an angel investment company focusing on technology and healthcare start-ups. Dr. Michael also served as a board member and acting president of Magnatas, a boutique consulting firm. Prior to these roles, Dr. Ackermann held positions at IQVIA as a senior vice president of global commercial solutions and at Eli Lilly and Company in various leadership roles, including global executive director of global strategic marketing support and US vice president of the neuroscience portfolio. Dr. Michael has extensive experience in the pharmaceutical industry and has played key roles in strategy development, launch planning, and commercialization activities.

Dr. Michael Ackermann, PhD, MBA has an extensive education history. Dr. Michael began their academic journey at Hampden-Sydney College, where they obtained a Bachelor of Science (BS) degree in Biology from 1976 to 1980. Following this, they pursued a Start of PhD program at the Virginia Commonwealth University School of Medicine from 1980 to 1982, specializing in Microbiology. Dr. Ackermann then moved to Drexel University College of Medicine, where they completed their Doctorate (Ph.D) in Immunology from 1982 to 1985.

In an effort to broaden their knowledge in management, Dr. Ackermann enrolled at the UNC Kenan-Flagler Business School from 1988 to 1990, earning himself a Master of Business Administration (MBA) degree in General Management.

Additionally, Dr. Ackermann has also participated in executive education at the prestigious Harvard Business School, focusing on Organizational Leadership. Dr. Michael has also undertaken Postdoctoral Studies in Immunology through the Fogerty International Fellowship at the National Institute of Health.